Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2005
10/27/2005CA2559698A1 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds
10/26/2005EP1589089A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same
10/26/2005EP1588709A1 Vitamin comprising pyroloquinoline quinone and use thereof
10/26/2005EP1587810A1 Novel substituted 1,4]benzodioxino 2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1440071B1 Imidazopyridine compounds as 5-ht 4? receptor modulators
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1381607B1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005EP1034793B1 Preventives/remedies for glaucoma
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005CN1688585A Antitumoral analogs of lamellarins
10/26/2005CN1688582A Fused azole-pyrimidine derivatives
10/26/2005CN1688581A [1, 2, 4]-triazole bicyclic adenosine A2a receptor antagonists
10/26/2005CN1688577A Triazaspiro [5.5] undecane derivatives and drugs comprising the same as the active ingredient
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688555A Novel bicyclic inhibitors of hormone sensitive lipase
10/26/2005CN1688311A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
10/26/2005CN1688194A 2, 4, 5-trisubstituted imidazoles and their use as anti-microbial agents
10/26/2005CN1687065A Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application
10/26/2005CN1224624C 1, 8-naphthyridin-2 (1H)-one derivatives
10/25/2005US6958417 Process for preparing zolpidem
10/25/2005US6958354 Pyrazole compounds as transforming growth factor (TGF) inhibitors
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958205 Image forming material and ammonium compound
10/25/2005CA2238170C Process for the production of endotropine
10/20/2005WO2005097806A1 Compounds and methods for treating dyslipidemia
10/20/2005WO2005097805A1 Compounds and methods for treating dyslipidemia
10/20/2005WO2005097800A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
10/20/2005WO2005097798A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments
10/20/2005WO2005097796A2 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
10/20/2005WO2005097795A1 Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
10/20/2005WO2005097794A1 Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
10/20/2005WO2005097793A1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
10/20/2005WO2005097792A1 Device and method for pneumatic valve control
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097790A1 Hetaryloxy-substituted phenylamino pyrimidines as rho kinase inhibitors
10/20/2005WO2005097789A1 Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
10/20/2005WO2005097788A2 Sulfonamides and uses thereof
10/20/2005WO2005097768A2 Novel gamma secretase inhibitors
10/20/2005WO2005097744A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005WO2005097129A2 6-azaindole compound
10/20/2005WO2005097107A2 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005WO2005009370A3 Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005WO2003106413A3 Process for the preparation of oxazolidinones and method of use thereof
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234102 Inhibiting the proteolytic activity of cathepsin S, comprising exposing cathepsin S to compounds such as 1-[4-(5-Chloro-1H-indol-3-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol
10/20/2005US20050234092 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/20/2005US20050234091 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]-4H-thieno[3,2-b]pyridin-7-one derivatives
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234084 Triazaspiro compounds useful for treating or preventing pain
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234059 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234056 Imidazoquinoline derivatives as adenosine A3 receptor ligands
10/20/2005US20050234053 9-oxo-3,4,6,9-tetrahydro-2H-[1,4]-(oxazino, thiazino, or pyrazino)[3,2-b][1,8]naphthyridine-8-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors
10/20/2005US20050234047 Respiratory syncytial virus replication inhibitors
10/20/2005US20050234042 Organic compounds
10/20/2005US20050234037 Compounds, compositions, and methods
10/20/2005US20050234029 Compounds
10/20/2005CA2563033A1 Novel gamma secretase inhibitors
10/20/2005CA2562399A1 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005CA2561801A1 Sulfonamides and uses thereof
10/20/2005CA2561210A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments
10/20/2005CA2560967A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity andthe monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005CA2560162A1 Inhibitors of iap
10/20/2005CA2558817A1 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
10/20/2005CA2557010A1 Compounds and methods for treating dyslipidemia
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585746A2 Naphthyridine derivatives and their use as fungicides
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585726A1 Fused heterocyclic derivatives as ppar modulators
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1585516A2 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP1202993B1 Phenanthroline-7-one derivatives and their therapeutic uses
10/19/2005EP1202728B1 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins.
10/19/2005EP1073656B1 Imidazo pyridine derivatives which inhibit gastric acid secretion
10/19/2005CN1684965A Novel 1, 4-diazabicycloalkane derivatives, their preparation and use
10/19/2005CN1684964A Use of and some novel imidazopyridines
10/19/2005CN1684963A Preparation of 1H-imidazo [4, 5-C] quinolin-4-amines via novel 1H-imidazo [4, 5-C] quinolin-4-cyano and 1H-imidazo [4, 5-C] quinolin-4-carboxamide intermediates
10/19/2005CN1684670A Methods and dosage forms for controlled delivery of paliperidone
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223349C Drug combination for treatment of depression and related disorders comprising mirtazapine
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956035 Isoquinoline derivatives and methods of use thereof
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/13/2005WO2005095406A1 Compositions useful as inhibitors of protein kinases
10/13/2005WO2005095402A1 Substituted 1,4,8-triazaspiro[4.5]decan-2-on compounds for use in the treatment of obesity
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 646